Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study 6/13/2024

Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial 6/13/2024

Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial 6/13/2024

Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases 6/13/2024

Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups 6/13/2024

Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report 6/13/2024

Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial 6/13/2024

Career Coach: How to Navigate 2 Job Interviews at the Same Company 6/13/2024

Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases 6/6/2024

Novo’s Ozempic, Wegovy to Face Stiff Generic Competition in China: Reuters 6/6/2024

Amgen Phase III Win Positions Uplizna for Label Expansion in Rare Autoimmune Disease 6/6/2024

BioSpace x DIA: Robust Integrated Regulatory Strategies 6/6/2024

Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report 6/6/2024

Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees 6/6/2024

Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow 6/6/2024

You’re More Than Your Job: Finding Self-Worth Outside of Work 6/6/2024

ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024

Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024

5 DMD Data Readouts to Watch in 2024 5/6/2024

AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024